37 phenotypes from 2 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Ncaldtm1.1(KOMP)Vlcg/Ncald+ B6N(Cg)-Ncaldtm1.1(KOMP)Vlcg/J	abnormal axon extension	J:273172
	normal growth/size/body region phenotype	J:273172
	normal nervous system phenotype	J:273172
Ncaldtm1.1(KOMP)Vlcg/Ncaldtm1.1(KOMP)Vlcg B6N(Cg)-Ncaldtm1.1(KOMP)Vlcg/J	abnormal axon extension	J:273172
	abnormal brain development	J:273172
	abnormal dentate gyrus subgranular zone morphology	J:273172
	abnormal hippocampus morphology	J:273172
	abnormal myelination	J:273172
	abnormal nervous system physiology	J:273172
	abnormal neuronal migration	J:273172
	decreased body weight	J:273172
	decreased brain size	J:273172
	decreased brain weight	J:273172
	decreased neuron number	J:273172
	dilated lateral ventricle	J:273172
	enlarged lateral ventricles	J:273172
	impaired neuron differentiation	J:273172
	reduced fertility	J:273172
	small hippocampus	J:273172
Ncaldtm1.1(KOMP)Vlcg/Ncaldtm1.1(KOMP)Vlcg C57BL/6N-Ncaldtm1.1(KOMP)Vlcg/J	abnormal behavior	J:211773
	abnormal bone structure	J:211773
	abnormal retina blood vessel morphology	J:211773
	abnormal retina vasculature morphology	J:211773
	abnormal sleep behavior	J:211773
	decreased bone mineral content	J:211773
	decreased bone mineral density	J:211773
	decreased prepulse inhibition	J:211773
	decreased thigmotaxis	J:211773
	hyperactivity	J:211773
	impaired pupillary reflex	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating insulin level	J:211773
	increased circulating sodium level	J:211773
	irregularly shaped pupil	J:211773
	mydriasis	J:211773
Ncaldtm1Rsha/Ncald+ involves: C57BL/6	increased systemic arterial systolic blood pressure	J:193415
Ncaldtm1Rsha/Ncaldtm1Rsha involves: C57BL/6	preweaning lethality, complete penetrance	J:193415